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Supplementary Table 1. Baseline characteristics and intermediate phenotypes in 
those men who went on to develop CHD and those men who remained disease free 






P- Value OR per 
tertile 
Age (years)  56.0 (3.5) 56.5 (3.6) 0.020  
Smoking (% Current) 6 27.6% 37.5% <0.001 1.57 
BMI (kg/m2)† 6 26.4 (3.55) 26.9 (3.38) 0.006 1.22 
SBP (mmHg) 6 137.6 (19.0) 142.6 (19.7) <0.001 1.27 
DBP (mmHg) 6 84.2 (11.2) 87.0 (11.4) <0.001 1.30 
Cholesterol (mmol/l) 6 5.70 (1.01) 6.05 (1.02) <0.001 1.43 
HDL (mmol/l) 1 1.72 (0.59) 1.60 (0.54) 0.002 0.77 
LDL (mmol/l) 1 3.06 (1.01) 3.36 (0.96) <0.001 1.39 
Triglyceride (mmol/l) 6 2.05 (1.26) 2.35 (1.34) <0.001 1.39 
ApoB (g/l) 1 0.89 (0.26) 0.95 (0.23) <0.001 1.53 
ApoAI (g/l) 1 1.64 (0.32) 1.61 (0.29) 0.151 0.89 
Homocysteine µmol/l 1 12.75 (5.06) 13.50 (5.65) 0.977 1.13 
Folate µmol/l 1 233.6 (64.6) 242.0 (70.1) 0.155 1.18 
Lp-PLA2 nmol/min/ml 1 49.4 (16.0) 50.6 (16.6) 0.200 1.15 






109.2 (28.9) 108.2 (29.7) 0.572 0.99 



















HMZ* % R2 MAF 
Triglycerides 
  
rs301 LPL 1.59E-06 0.01 -0.314 1.12 24.0 
  (1) (LDL) rs6589566 APOA5-A4-C3-A1 1.98E-05 0.01 0.633 0.91 7.0 
    E40K(2) ANGPTL4 2.23E-05 0.01 -0.420 0.69 2.1 
    rs264 LPL 2.46E-05 0.01 -0.217 0.89 15.1 
    rs662799 APOA5 3.15E-05 0.01 0.817 0.81 6.1 
    rs13702 LPL 6.20E-05 0.01 -0.247 0.81 28.4 
    rs3135506 APOA5 1.50E-04 0.02 1.076 0.71 5.7 
    rs3779788 LPL 2.26E-04 0.03 -0.184 0.70 15.3 
    rs5072 APOA5-A4-C3-A1 2.78E-04 0.03 0.527 0.69 7.3 
    rs579163 APOA5-A4-C3-A1 2.81E-04 0.03 0.258 0.69 32.6 
  (3) rs328 LPL 3.68E-04 0.03 -0.189 0.66 10.9 
    rs5128 APOA5-A4-C3-A1 6.05E-04 0.04 0.444 0.58 8.0 
    rs1131012 PECAM1 7.41E-04 0.05 -0.040 0.53 48.6 
    rs4075015 IL6R 1.04E-03 0.06 0.220 0.58 41.5 
    rs12285095 APOA5-A4-C3-A1 1.09E-03 0.06 0.880 0.57 5.9 
    rs4803455 TGFB1 1.25E-03 0.06 -0.022 0.56 49.9 
    rs7252574 (2) ANGPTL4 1.26E-03 0.06 -0.008 0.50 49.5 
    rs780094 GCKR 1.61E-03 0.07 0.213 0.48 37.8 
    rs268 LPL 1.81E-03 0.08 -0.964 0.53 2.1 
    rs4520 APOA5-A4-C3-A1 3.07E-03 0.11 0.298 0.45 21.3 
    rs4508523 LDLR 3.15E-03 0.11 0.298 0.48 12.5 
    rs5142 APOA5-A4-C3-A1 3.66E-03 0.12 0.211 0.47 8.0 
    rs3781600 LRP5 4.07E-03 0.13 0.858 0.46 8.4 
    rs3289 LPL 4.79E-03 0.14 1.267 0.45 2.7 
 
  rs3211719 F7 5.26E-03 0.15 0.269 0.44 24.6 
    rs316 LPL 5.42E-03 0.15 -0.463 0.44 11.9 
    rs7255436 (2) ANGPTL4 5.77E-03 0.16 -0.019 0.38 49.0 
    rs7746553 C2 6.21E-03 0.16 0.282 0.43 16.4 
    rs689 INS 6.39E-03 0.16 0.235 0.43 27.6 
    rs2479408 PCSK9 6.74E-03 0.16 0.215 0.42 19.9 
    rs11216157 APOA5-A4-C3-A1 7.08E-03 0.17 0.542 0.42 11.8 
    rs499718 PCSK9 7.53E-03 0.17 0.315 0.41 18.1 
    rs5128  APOA5-A4-C3-A1 7.77E-03 0.17 0.173 0.38 36.5 
    rs4417316 APOA5-A4-C3-A1 8.93E-03 0.19 -0.085 0.40 10.0 
    rs397211 ILRN1 9.08E-03 0.19 0.178 0.39 30.5 
    rs676210 APOB  1.02E-02 0.20 -0.213 0.38 21.5 
    rs11465699 IL18RAP 1.02E-02 0.20 -0.447 0.38 4.4 
Cholesterol   
rs429358/ 
rs7412 APOE-C1-C2-C4 1.09E-19 0.01 0.124 3.28 33.7 




(AD) rs4420638 APOE-C1-C2-C4 2.50E-06 0.01 0.405 1.08 19.1 
    rs6413504 LDLR 5.54E-06 0.01 0.293 1.01 49.0 
    rs2738446 LDLR 1.62E-05 0.01 0.273 0.92 45.3 
    rs2228671 LDLR 3.11E-05 0.01 -0.419 0.87 13.1 
    rs585967 APOB  1.60E-04 0.02 -0.391 0.73 14.8 
    rs12713843 APOB  1.69E-04 0.02 0.799 0.59 49.5 
    rs952275 APOB  4.02E-04 0.04 -0.222 0.66 49.2 
    rs12714264 APOB  5.07E-04 0.04 -0.322 0.64 13.5 
    rs11591147 PCSK9 1.04E-03 0.08 -2.741 0.56 0.9 
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    rs10199768 APOB  1.43E-03 0.10 0.213 0.55 44.0 
    rs7259004 APOE-C1-C2-C4 2.61E-03 0.16 -0.269 0.50 10.8 
    rs11602256 LRP5 3.35E-03 0.18 0.165 0.48 32.6 
    rs1367117 APOB  3.47E-03 0.18 0.216 0.47 32.8 
    rs934197 APOB  3.60E-03 0.18 0.216 0.47 32.7 
LDL-
cholesterol   
rs429358/ 
rs7412 APOE-C1-C2-C4 3.49E-17 0.01 0.116 3.34 33.2 
  (3), 4) rs6511720 LDLR 5.57E-07 0.01 -0.612 1.39 12.2 
    rs585967 APOB  1.51E-06 0.01 -0.564 1.29 14.6 
    rs2228671 LDLR 6.36E-06 0.01 -0.588 1.15 13.0 




(AD) rs4420638 APOE-C1-C2-C4 3.75E-05 0.01 0.469 0.98 18.8 
    rs952275 APOB  5.37E-05 0.01 -0.271 0.95 49.2 
    rs12691202 APOB  4.42E-04 0.04 -0.730 0.74 3.8 
    rs11591147 PCSK9 4.49E-04 0.04 -2.389 0.73 0.9 
    rs729287 ALX4 9.20E-04 0.08 -0.297 0.68 29.6 
    rs3740878 EXT2 1.11E-03 0.08 -0.291 0.66 29.9 
    rs8110695 LDLR 1.75E-03 0.12 -0.187 0.61 21.6 
    rs6413504 LDLR 2.10E-03 0.13 0.213 0.60 49.1 
    rs10199768 APOB  2.81E-03 0.15 0.215 0.57 44.3 
    rs7259004 APOE-C1-C2-C4 3.05E-03 0.15 -0.394 0.56 10.9 
    rs1051931 PLA2G7 3.09E-03 0.15 0.298 0.56 19.1 
    rs423490 C3 3.38E-03 0.15 -0.186 0.55 24.0 
    rs1051931 PLA2G7 3.41E-03 0.15 0.239 0.49 19.0 
    rs344548 C3 3.45E-03 0.15 -0.298 0.55 16.8 
    rs10811661 CDKN2A/2B 4.34E-03 0.17 -0.385 0.47 15.8 
    rs8112351 C3 4.80E-03 0.18 -0.188 0.52 23.9 
    rs3814309 GSTM3 5.52E-03 0.20 -0.063 0.50 32.0 
    rs1367117 APOB  5.81E-03 0.20 0.190 0.50 33.0 
HDL-
cholesterol   rs708272 CETP 8.88E-05 0.07 0.272 0.85 44.0 
    rs1729410 APOA5-A4-C3-A1 4.11E-04 0.13 0.221 0.76 43.2 
    rs1800588 LIPC 6.95E-04 0.13 0.313 0.71 20.9 
    rs264 LPL 8.25E-04 0.13 0.214 0.69 15.1 
    rs328 LPL 1.05E-03 0.14 0.459 0.60 10.3 
    rs4769060 ALOX5AP 1.92E-03 0.19 0.217 0.61 45.1 
ApoAI (3) (HDL) rs1800588 LIPC 4.94E-05 0.03 0.329 0.96 20.9 
    rs708272 CETP 6.90E-05 0.03 0.273 0.87 43.9 
    rs3885907 ALOX5AP 6.06E-04 0.15 0.240 0.71 45.7 
    rs1729410 APOA5-A4-C3-A1 7.45E-04 0.15 0.214 0.69 43.2 
    alu1(8) IGF2 9.53E-04 0.15 0.231 0.74 47.3 
    rs344550 C3 1.46E-03 0.20 0.033 0.63 34.8 
    rs5167 APOE-C1-C2-C4 1.76E-03 0.20 0.206 0.62 34.4 
    rs10162089 ALOX5AP 1.96E-03 0.20 0.220 0.60 47.9 
  
(3)(HDL, 
TG) rs328 LPL 2.22E-03 0.20 0.574 0.53 10.3 
APOB   
rs429358/ 
rs7412 APOE-C1-C2-C4 1.27E-16 0.01 0.068 3.16 33.2 
  (3) (LDL) rs11591147 PCSK9 4.41E-05 0.02 -3.130 0.95 0.9 
    rs7259004 APOE-C1-C2-C4 1.95E-04 0.06 -0.093 0.82 10.9 
    rs585967 APOB  8.31E-04 0.14 -0.333 0.68 14.6 
    rs952275 APOB  9.07E-04 0.14 -0.202 0.68 49.2 
    rs1537236 GSTM4 1.07E-03 0.14 0.060 0.66 48.8 
  
(3) (LDL); 
(5)(LDL) rs6511720 LDLR 1.25E-03 0.14 -0.199 0.64 12.2 
    rs1121923 LPL 1.71E-03 0.15 -1.984 0.61 3.0 
    rs729287 ALX4 1.75E-03 0.15 -0.295 0.61 29.6 
    rs3740878 EXT2 1.87E-03 0.15 -0.289 0.61 29.9 
    rs2738446 LDLR 2.28E-03 0.16 0.145 0.59 45.6 
    rs2228671 LDLR 2.43E-03 0.16 -0.387 0.58 13.0 
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Lp-PLA2   
rs429358/ 






(AD) rs4420638 APOE-C1-C2-C4 1.41E-06 0.01 0.490 1.48 19.5 
    rs3918232 NOS3 4.32E-04 0.12 -1.031 0.68 49.7 
BMI   6815A>T (8) IGF2 1.59E-05 0.02 -0.439 0.93 23.5 
    rs680 IGF2 4.81E-04 0.19 -0.302 0.60 26.9 
Fibrinogen   rs4508864 FGA-B-G 1.31E-07 0.01 0.425 1.32 18.9 
    rs1800790 FGB 2.74E-07 0.01 0.368 1.18 19.3 
    rs4220 FGA-B-G 9.66E-07 0.01 0.347 1.16 17.1 
    rs2070016 FGA-B-G 6.50E-06 0.01 0.377 1.00 14.8 
    rs1685354 UCP3 8.50E-04 0.14 0.311 0.59 25.2 
    rs1537236 GSTM4 1.61E-03 0.20 0.199 0.54 48.9 
    rs618923 ApoA5-A4-C3-A1 1.75E-03 0.20 -0.064 0.53 23.9 
FVII   rs6046 F7 
9.20E-
140 0.01 -2.154 23.59 10.3 
    insdel(10) F7 
1.89E-
126 0.01 -2.065 19.84 10.6 
    rs555212 F7 1.76E-34 0.01 0.814 6.33 23.8 
    -670A>C (10) F7 1.39E-31 0.01 0.806 6.06 23.2 
    -402G>C (10) F7 3.57E-22 0.01 0.580 3.96 25.1 
    rs867186 PROCR 5.81E-13 0.01 0.825 2.25 9.1 
    rs11576175 CTSS 2.39E-04 0.03 0.609 0.70 8.3 
    rs780094 GCKR 2.69E-04 0.03 0.234 0.61 37.8 
    rs4676411 CAPN10 1.84E-03 0.14 0.129 0.53 37.9 
    rs11602906 UCP2 1.95E-03 0.14 0.200 0.52 7.5 
    rs5167 APOE-C1-C2-C4 2.26E-03 0.15 0.048 0.52 34.3 
    rs6413504 LDLR 2.63E-03 0.16 0.193 0.50 48.9 
    rs3211719 F7 2.90E-03 0.17 0.281 0.51 24.6 
    rs11536857 TLR4 3.12E-03 0.17 0.698 0.48 7.8 
CRP   
rs429358/ 






(7)(AD) rs4420638 APOE-C1-C2-C4 2.41E-07 0.01 -0.401 1.39 19.4 
    rs3093077 CRP 1.03E-04 0.03 -0.245 0.75 33.7 
    rs1130864 CRP 2.19E-04 0.05 0.229 0.98 32.0 
    rs3091244 CRP 2.70E-04 0.05 0.188 0.67 5.4 
*Standardised difference  





Supplementary Table 3  Categories and candidate genes and the number of SNPs analysed in each,  included in the 768 Illumina bundle  
Inflammation genes Lipid genes  ROS genes Clotting genes T2D  Complement 
genes 
Genes of Interest CNV 
tSNPs   
IFNG 10 APOA2 11 CAT 13 F2 12 CALPAIN10 14 BF 13 GSK3 4      59 
IL10 7 APOB  39 GSTM1 5 F7 7   C2 8 G6PD 2  
IL18RAP 17 APOE-C1-C2-
C4 
13 GSTM3 7 FIBA-FIBB-FIBG 16 ALX4 1 C3 33 ZNF202 11  
IL1A 3 LPL 27 GSTM5 9  35 CAMTA1 1 CFD 7 ALOX5AP 26  
IL1B 6 LIPE 6 HMOX1 7   CXCR4??? 1 CFH 18 NDST1 9  
IL6 10 LRP1 21 HSPD1 3  CYBA 1  79 MMP3 6  
IL6R 14 SREBP1 4 NOS3 14  EXT2 1   CTSS 3  
IL6ST 10 A5-A4-C3-A1 35 SELS 9  HHEX 2   TIMP1 4  
ILRN1 12 LDLR 22 SOD2 14  KCNJ11 1    65  
LTA 11 LRP5 27 UCP2 8  KCTD12 1      
MYD88 4 PCSK9 21 UCP3 6  MMP26 1      
PLA2G7 13   226 PRDX5 3  NEUROG3 1      
PLA2GX 1   GSTM4 1  PSMA6 1     
TGFB1 8    99  SLC30A8 1     
TGFB3 9      rs1804451 1     
TLR2 13      rs1256517 1     
TLR4 20       29     
TNF 2            
 170            
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 Gene No of 
SNPs 
 Gene No of 
SNPs 
Gene No of 
SNPs 
Gene 
ACE 1  F2 1  LTBP4 1  TPO 2 
ADH1C 1  F5 1  LTBP4 7  UCP2 1 
ADIPOQ 4  F7 4  MMP3 1  UCP3 1 
ADRB1 1  FGA-B-G 4  MTHFR 1  VEGF 1 
ADRB3 1  FTO 1  MTP 3  WNT5 1 
AGT 8  GAL 1  MTR 1  ZNF202 1 
ANGPTL3 2  GCH1 1  NOS3 4    
ANGPTL4 7  GCKR 1  PCSK9 3    
APOA1-C3-A4-A5 11  GSTM1 1  PECAM1 3    
APOB 7  GSTT1 1  PLA2G5 2    
APOE 1  HABP2 1  PLA2G7 1    
ARH 1  IGF12 1  PLG 1    
AT1 1  IGF2 10  PON1 2    
AT2 2  IL18 8  PON2 1    
BK1 2  IL6 3  PON3 1    
BK2 2  INS 1  PPARA 3    
CBS 2  INSIG1 1  PPARD 1    
CDKN2A 2  LCAT 1  PPARG 3    
CETP 1  LDLR 2  PROCR 1    
CNR1 1  LIPC 1  SERPINA1 3    
CRP 4  LIPE 2  SERPINE1 1    
CTGF 1  LPL 5  TCF7L2 2    
CYP11P2 1  LTBP1 1  THBD 2    
F12 1  LTBP3 3  TNFA 1    
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Supplementary Table 5a List of Genes and SNPs with rs numbers included in 
the 768 Illumina bead Array 
 
 
rs Gene rs gene rs gene 
rs1256517 LOC646279 rs3766404 CFH rs17547610 LRP1 
rs1800764 ACE rs380390 CFH rs1800127 LRP1 
rs4459609 ACE rs402032 CFH rs1800159 LRP1 
rs2055049 AGTR1 rs419137 CFH rs1800168 LRP1 
rs2276736 AGTR1 rs460184 CFH rs2229278 LRP1 
rs388915 AGTR1 rs515299 CFH rs4759044 LRP1 
rs5182 AGTR1 rs534399 CFH rs715948 LRP1 
rs5186 AGTR1 rs7524776 CFH rs7304504 LRP1 
rs931490 AGTR1 rs1136774 CTSS rs7306742 LRP1 
rs10162089 ALOX5AP rs11576175 CTSS rs7398375 LRP1 
rs10507391 ALOX5AP rs7511673 CTSS rs7485650 LRP1 
rs11147439 ALOX5AP rs932206 CXCR4 rs7956957 LRP1 
rs12019512 ALOX5AP rs2254073 CYBA rs7968719 LRP1 
rs12429692 ALOX5AP rs3740878 EXT2 rs922963 LRP1 
rs17222814 ALOX5AP rs1799963 F2 rs11574422 LRP5 
rs17238738 ALOX5AP rs2070852 F2 rs11602256 LRP5 
rs17245120 ALOX5AP rs3136430 F2 rs11826287 LRP5 
rs17245317 ALOX5AP rs3136431 F2 rs12417792 LRP5 
rs3885907 ALOX5AP rs3136440 F2 rs2242340 LRP5 
rs3935644 ALOX5AP rs3136456 F2 rs2508836 LRP5 
rs4073261 ALOX5AP rs3136457 F2 rs312009 LRP5 
rs4075131 ALOX5AP rs3136520 F2 rs312014 LRP5 
rs4076128 ALOX5AP rs3136532 F2 rs312016 LRP5 
rs4254165 ALOX5AP rs4752930 F2 rs312786 LRP5 
rs4503649 ALOX5AP rs5896 F2 rs312788 LRP5 
rs4597169 ALOX5AP rs5898 F2 rs314756 LRP5 
rs4769055 ALOX5AP rs1475931 F7 rs3736228 LRP5 
rs4769060 ALOX5AP rs3093248 F7 rs3781596 LRP5 
rs4769873 ALOX5AP rs3211719 F7 rs3781600 LRP5 
rs4769875 ALOX5AP rs510317 F7 rs491347 LRP5 
rs9315051 ALOX5AP rs555212 F7 rs4930573 LRP5 
rs9508835 ALOX5AP rs574229 F7 rs4988300 LRP5 
rs9578196 ALOX5AP rs6046 F7 rs4988327 LRP5 
rs9579648 ALOX5AP rs1118823 FGA-B-G rs4988331 LRP5 
rs9671124 ALOX5AP rs1800788 FGA-B-G rs587397 LRP5 
rs729287 ALX4 rs1800792 FGA-B-G rs606989 LRP5 
rs11590967 APOA2 rs2066860 FGA-B-G rs608343 LRP5 
rs12721035 APOA2 rs2066870 FGA-B-G rs624947 LRP5 
rs1803091 APOA2 rs2070016 FGA-B-G rs638051 LRP5 
 8 
rs2070902 APOA2 rs2070018 FGA-B-G rs676318 LRP5 
rs3557 APOA2 rs2070022 FGA-B-G rs7116604 LRP5 
rs5082 APOA2 rs2070025 FGA-B-G rs1041981 LTA 
rs5085 APOA2 rs4220 FGA-B-G rs1799964 LTA 
rs3813627 APOA2   rs4463047 FGA-B-G rs1800629 LTA 
rs4233368 APOA2   rs4508864 FGA-B-G rs1800683 LTA 
rs4489574 APOA2   rs6054 FGA-B-G rs2009658 LTA 
rs7528588 APOA2   rs7659024 FGA-B-G rs2071590 LTA 
rs11216157 ApoA5-A4-C3-
A1 
rs7659613 FGA-B-G rs2229094 LTA 
rs11216159 ApoA5-A4-C3-
A1 
rs7673587 FGA-B-G rs2844484 LTA 
rs12284864 ApoA5-A4-C3-
A1 
rs1050828 G6PD rs3093662 LTA 
rs12285095 ApoA5-A4-C3-
A1 
rs2230037 G6PD rs3093668 LTA 
rs12365440 ApoA5-A4-C3-
A1 
rs2302485 GSK3 rs915654 LTA 
rs12365462 ApoA5-A4-C3-
A1 
rs3745233 GSK3 rs2499953 MMP26 
rs1263173 ApoA5-A4-C3-
A1 
rs3810149 GSK3 rs3025090 MMP3 
rs12718464 ApoA5-A4-C3-
A1 
rs708598 GSK3 rs476762 MMP3 
rs1729410 ApoA5-A4-C3-
A1 
rs12068997 GSTM1 rs522616 MMP3 
rs2071521 ApoA5-A4-C3-
A1 
rs12097277 GSTM1 rs527832 MMP3 
rs2071523 ApoA5-A4-C3-
A1 
rs12562055 GSTM1 rs650108 MMP3 
rs2075291 ApoA5-A4-C3-
A1 
rs4147565 GSTM1 rs679620 MMP3 
rs2075294 ApoA5-A4-C3-
A1 
rs4147567 GSTM1 rs6796045 MYD88 
rs2098453 ApoA5-A4-C3-
A1 
rs1055259 GSTM3 rs6853 MYD88 
rs2216311 ApoA5-A4-C3-
A1 
rs1332018 GSTM3 rs7625290 MYD88 
rs2727789 ApoA5-A4-C3-
A1 
rs1537234 GSTM3 rs7744 MYD88 
rs2849174 ApoA5-A4-C3-
A1 
rs1803687 GSTM3 rs10074650 NDST1 
rs33989105 ApoA5-A4-C3-
A1 
rs2234696 GSTM3 rs11959543 NDST1 
rs35625356 ApoA5-A4-C3-
A1 
rs3814309 GSTM3 rs12516924 NDST1 
rs35631472 ApoA5-A4-C3-
A1 
rs4970737 GSTM3 rs2273232 NDST1 
rs35833621 ApoA5-A4-C3-
A1 
rs1537236 GSTM4 rs2273233 NDST1 
rs4417316 ApoA5-A4-C3-
A1 
rs10776699 GSTM5 rs2545342 NDST1 
rs5072 ApoA5-A4-C3-
A1 




rs11807 GSTM5 rs3095902 NDST1 
rs5142 ApoA5-A4-C3-
A1 
rs12743015 GSTM5 rs3797621 NDST1 
rs579163 ApoA5-A4-C3-
A1 
rs366631 GSTM5 rs10823406 NGN3 
rs595049 ApoA5-A4-C3-
A1 
rs3768490 GSTM5 rs10277237 NOS3 
rs601634 ApoA5-A4-C3-
A1 
rs4970772 GSTM5 rs1799983 NOS3 
rs603446 ApoA5-A4-C3-
A1 
rs886177 GSTM5 rs1800779 NOS3 
rs618354 ApoA5-A4-C3-
A1 
rs929166 GSTM5 rs1800783 NOS3 
rs618923 ApoA5-A4-C3-
A1 
rs1111875 HHEX rs2070744 NOS3 
rs6589566 ApoA5-A4-C3-
A1 
rs7923837 HHEX rs2373929 NOS3 
rs6589567 ApoA5-A4-C3-
A1 
rs11912889 HMOX1 rs3918166 NOS3 
rs6589568 ApoA5-A4-C3-
A1 
rs2071746 HMOX1 rs3918186 NOS3 
rs9804646 ApoA5-A4-C3-
A1 
rs2285112 HMOX1 rs3918188 NOS3 
rs10199768 APOB  rs5755713 HMOX1 rs3918201 NOS3 
rs1042031 APOB  rs5755720 HMOX1 rs3918227 NOS3 
rs11126598 APOB  rs743811 HMOX1 rs3918232 NOS3 
rs11676704 APOB  rs9282702 HMOX1 rs3918234 NOS3 
rs12691202 APOB  rs2340690 HSPD1 rs743507 NOS3 
rs12713450 APOB  rs6434930 HSPD1 rs10465832 PCSK9 
rs12713540 APOB  rs788016 HSPD1 rs10888896 PCSK9 
rs12713554 APOB  rs10878763 IFNG rs11206514 PCSK9 
rs12713559 APOB  rs11177074 IFNG rs11583680 PCSK9 
rs12713675 APOB  rs2069709 IFNG rs13312 PCSK9 
rs12713843 APOB  rs2069713 IFNG rs17111495 PCSK9 
rs12714097 APOB  rs2069716 IFNG rs2182833 PCSK9 
rs12714214 APOB  rs2069718 IFNG rs2479406 PCSK9 
rs12714225 APOB  rs2069720 IFNG rs2479408 PCSK9 
rs12714264 APOB  rs2069727 IFNG rs2479409 PCSK9 
rs12720791 APOB  rs2069728 IFNG rs2495481 PCSK9 
rs12720801 APOB  rs3181033 IFNG rs4927193 PCSK9 
rs12720843 APOB  rs1800871 IL10 rs499718 PCSK9 
rs12720848 APOB  rs1800890 IL10 rs505151 PCSK9 
rs12720854 APOB  rs1878672 IL10 rs529787 PCSK9 
rs13306187 APOB  rs3021094 IL10 rs533375 PCSK9 
rs1367117 APOB  rs3024505 IL10 rs557435 PCSK9 
rs1713223 APOB  rs3024509 IL10 rs562556 PCSK9 
rs17398765 APOB  rs6673928 IL10 rs568052 PCSK9 
rs1801700 APOB  rs11465699 IL18RAP rs572512 PCSK9 
rs1801701 APOB  rs11465716 IL18RAP rs7552841 PCSK9 
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rs1801702 APOB  rs11465724 IL18RAP rs9804032 PCSK9 
rs1801703 APOB  rs11465730 IL18RAP rs1051931 PLA2G7 
rs2163204 APOB  rs11465732 IL18RAP rs10948300 PLA2G7 
rs2854725 APOB  rs11695455 IL18RAP rs12195701 PLA2G7 
rs520354 APOB  rs11886793 IL18RAP rs12528807 PLA2G7 
rs533617 APOB  rs17027173 IL18RAP rs1421368 PLA2G7 
rs550619 APOB  rs17821875 IL18RAP rs1421378 PLA2G7 
rs584542 APOB  rs2075186 IL18RAP rs16874962 PLA2G7 
rs585967 APOB  rs2293225 IL18RAP rs17288905 PLA2G7 
rs6752026 APOB  rs3771150 IL18RAP rs1805018 PLA2G7 
rs676210 APOB  rs6543139 IL18RAP rs2216465 PLA2G7 
rs679899 APOB  rs6741230 IL18RAP rs4498351 PLA2G7 
rs934197 APOB  rs7559479 IL18RAP rs6929105 PLA2G7 
rs952275 APOB  rs7559845 IL18RAP rs974670 PLA2G7 
rs10413089 APOE-C1-C2-C4 rs917998 IL18RAP rs584367 PLA2GX 
rs12691089 APOE-C1-C2-C4 rs17561 IL1A rs11600990 PRDX5 
rs405509 APOE-C1-C2-C4 rs2071373 IL1A rs4930702 PRDX5 
rs429358 APOE-C1-C2-C4 rs2856838 IL1A rs9787810 PRDX5 
rs439401 APOE-C1-C2-C4 rs1143630 IL1B rs1048990 PSMA6 
rs4420638 APOE-C1-C2-C4 rs1143634 IL1B rs12438654 SELS 
rs4803770 APOE-C1-C2-C4 rs1143643 IL1B rs2101171 SELS 
rs5112 APOE-C1-C2-C4 rs16944 IL1B rs2291250 SELS 
rs5126 APOE-C1-C2-C4 rs2853550 IL1B rs2306534 SELS 
rs5127 APOE-C1-C2-C4 rs4848306 IL1B rs4965372 SELS 
rs5167 APOE-C1-C2-C4 rs10242595 IL6 rs4965815 SELS 
rs7259004 APOE-C1-C2-C4 rs10499563 IL6 rs7178239 SELS 
rs7259679 APOE-C1-C2-C4 rs11766273 IL6 rs8036413 SELS 
rs1048709 BF rs12700386 IL6 rs9874 SELS 
rs1270942 BF rs13306435 IL6 rs13266634 SLC30A8 
rs2072633 BF rs1800795 IL6 rs1804451 SOD2 
rs4151651 BF rs1800796 IL6 rs2758329 SOD2 
rs4151657 BF rs2069830 IL6 rs2758331 SOD2 
rs4151659 BF rs2069840 IL6 rs2842980 SOD2 
rs4151660 BF rs2069861 IL6 rs2855115 SOD2 
rs4151664 BF rs11584622 IL6R rs4342445 SOD2 
rs4151667 BF rs1386821 IL6R rs4987023 SOD2 
rs537160 BF rs1552481 IL6R rs5746101 SOD2 
rs641153 BF rs28730736 IL6R rs5746128 SOD2 
rs9332730 BF rs4075015 IL6R rs5746129 SOD2 
rs9501161 BF rs4240872 IL6R rs5746133 SOD2 
rs2734335 C2 rs4329505 IL6R rs5746136 SOD2 
rs3020644 C2 rs4601580 IL6R rs5746151 SOD2 
rs4151648 C2 rs4845615 IL6R rs7855 SOD2 
rs497309 C2 rs4845617 IL6R rs9456442 SOD2 
rs547154 C2 rs4845618 IL6R rs11656665 SREBP1 
rs7746553 C2 rs6684439 IL6R rs2228461 SREBP1 
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rs9267677 C2 rs7526293 IL6R rs2229590 SREBP1 
rs9332739 C2 rs8192284 IL6R rs4925118 SREBP1 
rs1047286 C3 rs10076283 IL6ST rs10417924 TGFB1 
rs11569422 C3 rs10180 IL6ST rs12980942 TGFB1 
rs11569429 C3 rs1063560 IL6ST rs1800469 TGFB1 
rs11569450 C3 rs10940495 IL6ST rs1800471 TGFB1 
rs11569523 C3 rs11574780 IL6ST rs1800472 TGFB1 
rs11569534 C3 rs1900173 IL6ST rs4803455 TGFB1 
rs11569538 C3 rs2228043 IL6ST rs8110090 TGFB1 
rs11569541 C3 rs2228046 IL6ST rs8179181 TGFB1 
rs11672613 C3 rs3729960 IL6ST rs11466414 TGFB3 
rs1389623 C3 rs6870870 IL6ST rs2268625 TGFB3 
rs163913 C3 rs17486819 ILRN1 rs2268626 TGFB3 
rs2230199 C3 rs2637988 ILRN1 rs3917148 TGFB3 
rs2230203 C3 rs3087263 ILRN1 rs3917158 TGFB3 
rs2230204 C3 rs315920 ILRN1 rs3917200 TGFB3 
rs2230205 C3 rs315936 ILRN1 rs3917210 TGFB3 
rs2230210 C3 rs315946 ILRN1 rs4252315 TGFB3 
rs2241393 C3 rs315952 ILRN1 rs7156293 TGFB3 
rs2241394 C3 rs380092 ILRN1 rs13440825 TIMP1 
rs2250656 C3 rs397211 ILRN1 rs2070584 TIMP1 
rs2277984 C3 rs4251961 ILRN1 rs2077407 TIMP1 
rs237554 C3 rs4252019 ILRN1 rs6520278 TIMP1 
rs2642196 C3 rs4252041 ILRN1 rs11938228 TLR2 
rs344540 C3 rs5219 KCNJ11 rs1339 TLR2 
rs344548 C3 rs2876711 KCTD12 rs1898830 TLR2 
rs344550 C3 rs10409044 LDLR rs3804099 TLR2 
rs344555 C3 rs11669576 LDLR rs3804100 TLR2 
rs3745568 C3 rs12608650 LDLR rs4696480 TLR2 
rs379527 C3 rs13306505 LDLR rs4696483 TLR2 
rs423490 C3 rs13306510 LDLR rs5743699 TLR2 
rs432001 C3 rs1799898 LDLR rs5743703 TLR2 
rs432823 C3 rs2228671 LDLR rs5743704 TLR2 
rs7257062 C3 rs2569540 LDLR rs5743708 TLR2 
rs8112351 C3 rs2738446 LDLR rs720633 TLR2 
rs1193179 CAMTA1 rs2738459 LDLR rs7656411 TLR2 
rs10933621 CAPN10 rs2738460 LDLR rs893629 TLR2 
rs1133353 CAPN10 rs2738464 LDLR rs10759930 TLR4 
rs11680323 CAPN10 rs4508523 LDLR rs10818073 TLR4 
rs2953147 CAPN10 rs5927 LDLR rs11536857 TLR4 
rs2953149 CAPN10 rs5928 LDLR rs11536869 TLR4 
rs2953161 CAPN10 rs5930 LDLR rs11536889 TLR4 
rs2975766 CAPN10 rs5931 LDLR rs11536897 TLR4 
rs3749164 CAPN10 rs6413504 LDLR rs1554973 TLR4 
rs3792267 CAPN10 rs6511720 LDLR rs16906079 TLR4 
rs3792270 CAPN10 rs7508676 LDLR rs1927906 TLR4 
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rs3792272 CAPN10 rs8108932 LDLR rs1927907 TLR4 
rs3828345 CAPN10 rs8110695 LDLR rs2149356 TLR4 
rs4234123 CAPN10 rs10099160 LPL rs2770144 TLR4 
rs4676411 CAPN10 rs1121923 LPL rs2770150 TLR4 
rs10488736 CAT rs13702 LPL rs4987233 TLR4 
rs11032699 CAT rs1534649 LPL rs5030717 TLR4 
rs11032702 CAT rs17410577 LPL rs5030718 TLR4 
rs11032703 CAT rs1800590 LPL rs5030719 TLR4 
rs16925614 CAT rs1801177 LPL rs5031050 TLR4 
rs208682 CAT rs2197089 LPL rs7044464 TLR4 
rs2266630 CAT rs248 LPL rs7869402 TLR4 
rs2284368 CAT rs249 LPL rs2507961 TNF 
rs511895 CAT rs253 LPL rs4645843 TNF 
rs554518 CAT rs264 LPL rs1050892 UCP2 
rs564250 CAT rs268 LPL rs11602906 UCP2 
rs566979 CAT rs270 LPL rs2306820 UCP2 
rs7933285 CAT rs281 LPL rs2632725 UCP2 
rs7947841 CAT rs283 LPL rs643064 UCP2 
rs12985692 CFD rs285 LPL rs655717 UCP2 
rs13090 CFD rs298 LPL rs659366 UCP2 
rs1651895 CFD rs301 LPL rs660339 UCP2 
rs1683564 CFD rs316 LPL rs1685354 UCP3 
rs17684161 CFD rs328 LPL rs1800849 UCP3 
rs2230216 CFD rs3289 LPL rs2229707 UCP3 
rs3826945 CFD rs3779788 LPL rs2734827 UCP3 
rs1061170 CFH rs4921684 LPL rs3781907 UCP3 
rs1065489 CFH rs5934 LPL rs7926165 UCP3 
rs10801560 CFH rs7016529 LPL rs1077911 ZNF202 
rs10922096 CFH rs9644636 LPL rs10893079 ZNF202 
rs1329421 CFH rs10783814 LRP1 rs11219263 ZNF202 
rs1329423 CFH rs10876966 LRP1 rs11219270 ZNF202 
rs17434860 CFH rs11172113 LRP1 rs12794996 ZNF202 
rs2019727 CFH rs12369345 LRP1 rs1557429 ZNF202 
rs3753394 CFH rs12578897 LRP1 rs2282641 ZNF202 
rs3753395 CFH rs12814239 LRP1 rs2282646 ZNF202 
  rs1466535 LRP1 rs3183878 ZNF202 
    rs597530 ZNF202 
    rs9326264 ZNF202 
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Supplementary Table 5b List of CNV SNPs with rs numbers included in the 768 Illumina bead Array 
 
 
       
 


























Supplementary Table 6. Comparison between statistically significant SNPs and independent genetic 
loci associated with each of the phenotypes tested.  Arrangement into loci using LD clumping in 
PLINK with an R2 of 0.01. 
 
 
Trait Significant  
SNPs 
Independent 
SNPs or loci 
no. 
genes 
Triglycerides 37 20 16 
Cholesterol 16 7 5 
LDL-cholesterol 23 8 10 
HDL-cholesterol 6 6 5 
ApoAI 9 7 7 
APOB 12 7 8 
Lp-PLA2 3 2 2 
BMI 2 1 1 
Fibrinogen 7 3 4 
FVII 14 9 9 
CRP 5 2 2 
Total 134 72 69 
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Supplementary Table 7. Additional genes, SNPs and their rs numbers genotyped in NPHSII 
Rs number 
/SNP     
Gene Rs number /SNP    Gene Rs number 




ACE rs429358 APOE c2207t (12) IGF2 
rs698 ADH1C rs7412 APOE rs2230949 IGF2  
rs17300539 ADIPOQ rs5186 AT1 c2722t (12) IGF2 
rs1501299 ADIPOQ rs1675 (13) AT2 c8173t (12) IGF2 
rs266729 ADIPOQ 3123 (13) AT2 AluI(12) IGF2 
rs2241766 ADIPOQ -699G>C(14) BDKRB1 rs680 IGF2 
rs1801253 ADRB1 Ex1del/ins 
9bp(14) 
BDKRB2 rs3741211 IGF2 
rs4994 ADRB3 Ex8 del/ins 
68bp(15) 
CBS rs360729 IL18 
rs2067853 AGT rs10757274 CDKN2A rs549908 IL18 
rs11122574 AGT rs2383206 CDKN2A rs1946519 IL18 
rs11122580 AGT rs708272 CETP rs2043055 IL18 
rs3789679 AGT rs2229579 CNR1 rs3882891 IL18 
rs11568030 AGT rs1130864 CRP rs3814721 IL18 
rs6687360 AGT rs1205 CRP rs2298455 IL18 
rs3789666 AGT rs3093077 CRP rs1541304    IL18 
rs10864772 AGT rs3091244 CRP rs1800795 IL6 
rs 2031373  ANGPTL3 rs6918698 CTGF    rs1800796 IL6 
rs 12042319  ANGPTL3 rs1799998 CYP11P2 rs10499563 IL6 
rs4076317  ANGPTL4 rs4314418 F12 rs689 INS 
rs7255436 ANGPTL4 20210G-A(16) F2 rs7566605  INSIG1 
rs1044250 ANGPTL4 rs6025 F5 rs4986970 LCAT 
rs11672433 ANGPTL4 -670A>C (17) F7 rs11669576 LDLR 
rs7252574 ANGPTL4 rs6046 F7 rs45508991 LDLR 
rs1808536 ANGPTL4 -402G>A (17) F7 -514C>T(18) LIPC 
g118a 
E40K(19) 
ANGTPL4 In/del(17) F7 -60C>G(20) LIPE  
rs670 APOA1 rs2070011 FGA In4T>C(20) LIPE  
rs675 APOA4 rs1800790 FGB rs1801177 LPL 
rs5110 APOA5 rs1800791 FGB/G rs1800590 LPL 
rs3135506 APOA5 rs1421085 FTO -95G>T (21) LPL  
rs662799 APOA5 rs2187331 GAL rs268 LPL 
rs1729408 APOA5-A4 rs780094 GCKR Rs328 LPL 
rs693 APOB mu-1(22) GSTM1 256G>C LTBP1 
rs1801701 APOB theta-1(22) GSTT1 rs947791 LTBP3 
rs1042031 APOB rs7080536  HABP2 rs4244811 LTBP3 
Ins/del(23) APOB rs7873 IGF12 rs11601767 LTBP3 
rs4520 APOC3 rs1003483 IGF2 rs2369006 LTBP4 
3’utr g>(24) APOC3 a6815t(12) IGF2 rs393569 LTBP4 








Supplementary Table 8. Power calculation showing the effect sizes that could be detected at 80% 













MAF Rare Hz St Effect size 
0.05 0.0025 1.702 
0.1 0.01 0.8463 
0.2 0.04 0.4467 
0.3 0.09 0.3223 
0.4 0.16 0.2653 
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 BMI Systolic Diastolic Cholesterol HDL LDL Triglycerides APOB APOA Homocyst Folate LpPLA2 CRP F7 
Systolic 1.85E-21                           
Diastolic 6.57E-33 6.39e-315                         
Cholesterol 2.76E-06 4.58E-06 9.45E-05                       
HDL 7.27E-17 8.50E-05 1.87E-12 5.23E-01                     
LDL 3.97E-03 1.99E-01 5.03E-01 1.00E-250 6.15E-10                   
Triglycerides 1.64E-75 2.75E-25 3.57E-29 2.85E-75 1.58E-123 3.94E-04                 
APOB 8.69E-14 9.17E-04 1.94E-01 2.06E-245 7.28E-10 4.21E-166 5.26E-41               
APOA 1.68E-12 9.13E-01 8.05E-02 3.74E-07 1.27E-123 1.18E-01 2.67E-27 2.72E-37             
Homocyst 7.11E-02 6.34E-04 8.07E-02 4.75E-01 7.05E-01 5.98E-01 6.27E-01 2.49E-01 1.66E-01           
Folate 2.39E-05 2.99E-01 6.57E-01 1.63E-01 8.09E-01 8.84E-01 3.35E-05 7.24E-01 3.20E-01 1.12E-78         
LpPLA2 1.30E-04 3.61E-05 4.39E-05 6.29E-53 5.61E-24 1.71E-29 1.80E-29 2.34E-17 4.75E-04 1.15E-01 6.03E-01       
CRP 1.79E-40 1.08E-14 2.96E-08 1.30E-07 1.09E-20 7.68E-04 4.51E-34 8.93E-11 1.52E-16 5.54E-02 1.14E-01 4.30E-02     
F7 5.78E-06 1.09E-05 1.27E-08 1.32E-35 1.94E-01 3.05E-07 7.25E-49 6.40E-20 2.19E-01 1.26E-02 6.25E-01 7.79E-01 2.00E-11   
FIB 7.05E-05 1.91E-08 3.54E-03 1.95E-07 9.38E-17 1.13E-07 1.44E-04 2.01E-15 1.34E-15 1.98E-02 1.55E-01 3.92E-01 3.86E-126 1.04E-0
 
Supplementary Figure 1 Correlation between continuous phenotypes in men from the Northwick Park Heart Study 




Supplementary Figure 2 Correlations between protein phenotypes linked to CHD in 2775 men from the NPHS-II  
Study. Values in cells indicate Pearson’s correlation co-efficient r.  * p<0.01, ** p<0.001. 
  ApoB ApoAI LpPLA2 CRP F7 
ApoAI -0.2433**         
LpPLA2 0.193** -0.0802**       
CRP 0.1344** -0.1707** 0.0433*     
F7 0.1755** 0.0238 0.0058 0.1277**   
FIB 0.1528** -0.1538** 0.0178 0.434** 0.0942 
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Supplementary Figure 3: Power calculation plot showing the relationship between MAF and effect size  
 
 
